24/7 Patient Assistance: 760-405-8205

Richard Lopez, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

UAB Hospital

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Photodynamic Therapy Targeted Therapy

  • Bio & Insurance Information

    Dr. Richard Lopez graduated the medical school from Stanford University School of Medicine and completed his residency program at the same university. He is specialized in Medical Oncology and also board certified in Medical Oncology. Dr. Lopez has been in practice for more than 20 years and is affiliated with University of Alabama Hospital. During his career, he has contributed to several publications of medical interest.

    Insurance Accepted

    AetnaCignaFirst Health PPOHumanaMultiPlan

  • Education & Training

    dept_icon

    Stanford University

    Medical School

    dept_icon

    Stanford University

    Internship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    UAB Hospital

    Languages: English/Spanish

    (205) 934-3411

    1802 6th Ave S

    Birmingham, Alabama 35233

    Read More
  • Publications & Memberships

    Dr. Richard Lopez has contributed to 3 publications.

    LKB1 reduces ROS-mediated cell damage via activation of p38.

    Xu, H. G.,Zhai, Y. X.,Chen, J.,Lu, Y.,Wang, J. W.,Quan, C. S.,Zhao, R. X.,Xiao, X.,He, Q.,Werle, K. D.,Kim, H. G.,Lopez, R.,Cui, R.,Liang, J.,Li, Y. L.,Xu, Z. X.; Oncogene. 2014 Sep 30.

    See more >>

    Inhibiting inhibitory pathways in human γδ T cells.

    Lopez, R. D.; Blood. 2013 Aug 10.

    See more >>

    Alemtuzumab for the prevention and treatment of graft-versus-host disease.

    January, C.T., Makielski, J.C., Duff, H.; Int J Hematol. 2011 May.

    See more >>